Clinical Trials
9 trialsNCT05997342 2025-08-11
A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Completed
NCT06344351 2025-05-22
A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Completed
NCT06297642 2024-08-06
TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Terminated
NCT06394713 2024-05-01
A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
NCT06165809 2023-12-29
A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Withdrawn
NCT06165822 2023-12-12
A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT05867563 2023-07-10
Clinical Trial Evaluating the Safety of the TQB2103 for Injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT05048160 2022-05-09
A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2 Unknown
NCT03051035 2021-09-20
First-in-Human Study of KO-947 in Non-Hematological Malignancies
Kura Oncology, Inc.
Phase 1 Terminated